Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV002484962 | SCV002778912 | uncertain significance | Arrhythmogenic right ventricular dysplasia 9 | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002484962 | SCV003441069 | likely benign | Arrhythmogenic right ventricular dysplasia 9 | 2023-05-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004806100 | SCV005429534 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2024-04-16 | criteria provided, single submitter | clinical testing | This missense variant replaces glutamine with leucine at codon 59 of the PKP2 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function. This variant has been reported to occur in 0.3% of the Finnish population (PMID: 21397041) and claimed to be a founder mutation in that population. This variant has been identified in 21/246924 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Blueprint Genetics | RCV000157408 | SCV000207147 | uncertain significance | AV junctional rhythm; Ventricular tachycardia | 2014-08-22 | no assertion criteria provided | clinical testing |